Navigation Links
Surgical technique in Spain enables extirpation of benign tumors of the pancreas
Date:2/3/2009

This release is available in Spanish.

This minimally invasive procedure, pioneering in Spain, has been developed by a team of surgeons at the University Hospital of Navarra, which brings together the greatest experience worldwide in this technique.

The results obtained in patients were recently published in the specialised surgery journal of greatest international impact, Annals of Surgery. It is the highest number of patients operated on using laparoscopic central pancreatectomy and that has been published in scientific literature worldwide. The specialists who took part in the study and who undertook the surgical technique are Doctors Fernando Pardo, Fernando Rotellar and Custodia Montiel, surgeons at the University Hospital of Navarra

As Doctor Pardo, Director of the Hepatobiliopancreatic Surgery service states, this technique has been recognised as a feasible procedure that reduces complications and hospitalisation periods, in a highly specific pancreatic pathology. The main achievement is having managed to devise a laparoscopic surgery technique for operations which to date has only been possible through open surgery. This new laparoscopic method is much less invasive and enables a large part of the gland to be conserved, and thus avoids the appearance of post-operative diabetes.

Complex technique - excellent results

The results of the laparoscopic central pancreatectomy have been excellent, according to Doctor Rotellar, and can even exceed those achieved by open surgery. According to this specialist, the laparoscopic technique reduces complications compared to open surgery. The period of hospitalisation is reduced from the average of ten days with the conventional procedure to four days with laparoscopy. The much lower rates for side effects also bear on reduced hospitalisation periods.

The tumours that these operations target are mainly neuroendocrine or cystic tumours of the pancreas that are benign or of low malignant potential. These lesions are diagnosed with greater frequency amongst young women, with an average age of 30, states Doctor Rotellar. Thus, the principal goal of this procedure is to obtain the optimum precision surgery in such a way that we are able to preserve the pancreas to the maximum. This is why laparoscopic central pancreatectomy is not suitable for tumours of poorer prognosis where it is paramount to operate radically in order to avoid a future regeneration of the tumour.

The importance of this surgical technique lies in managing to extirpate the minimum portion possible of the pancreas and, consequently, avoid the risk of the patient developing an intolerance to glucose or diabetes, besides any digestive problems that may arise from the lack of pancreatic enzymes, pointed out Doctor Pardo.

The surgeon also stated that laparoscopic central pancreatectomy is a pioneering technique, given its complex nature (after extirpating a portion of the pancreas, an anastomosis or union of the pancreatic duct with the intestine is carried out by laparoscopy). This joining to the intestine is necessary for the pancreas to be able to secrete its juices into it and, thus, it is a highly delicate operation.


'/>"/>

Contact: Oihane Lakar
oihane@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. New study shows promise in reducing surgical risks associated with surgical bleeding
2. Pioneer Surgical Technology Hires Vice President of New Business Development
3. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
4. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
5. Revolutionary HD Surgical Footage from North Shore-LIJ Surgeon to be Broadcast for the First Time on ABCs 20/20, National Geographic Channel
6. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
7. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
8. Study finds limiting work hours for surgical residents enhances training
9. STAAR Surgical Reports Operational Progress
10. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
11. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 2016 , ... For many years, Andrew G. Zubinas has accumulated ... beauty of the Lithuanian language and its poetry inspired him in writing ... lyrically explores all aspects of a living, breathing forest where nothing ever stays the ...
(Date:12/5/2016)... Atlanta, GA (PRWEB) , ... ... ... information technology and security executive networking and relationship-marketing firm, announced today that ... for the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include ...
(Date:12/5/2016)... Novato, CA (PRWEB) , ... December 05, 2016 ... ... company, has extended its partnership with leading global lifestyle design firm kathy ireland® ... , Worldwise® and kathy ireland® Worldwide entered into an exclusive licensing agreement three ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive ... of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , NitroGenesis ... shown to produce NO twice as effectively and sustains NO blood levels twice ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... announced that the company will provide alerting technology to Central Illinois Health ... awarded $1.7 million in federal funds as the sole sub-recipient participating with ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... LAKE OSWEGO, Ore. , Dec. 5, 2016 /PRNewswire/ ... in the BioInsight clinical study. The study evaluates the ... 2 insertion procedure in an office setting. ... ProMRI ® technology that is placed underneath a ... atrial fibrillation and syncope (fainting). Atrial fibrillation is a ...
(Date:12/5/2016)... and Gateway Health proudly announce a dynamic collaboration that will ... members with specific high risk needs. In an ... of consumers, Wellbridge combines technology and population expertise with a ... daily behaviors and lifestyle. ... , , "Dealing ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, ... Sankyo) today announced preliminary safety and efficacy data ... investigational oral selective MDM2 inhibitor, suggesting that DS-3032 ... including relapsed/refractory acute myeloid leukemia (AML) and high-risk ... escalation part of the phase 1 study of DS-3032 ...
Breaking Medicine Technology: